Used in pharmaceutical research as a potent and selective inhibitor of certain kinase enzymes involved in inflammatory and immune-mediated diseases. Shows promising activity in preclinical models for treating autoimmune disorders such as rheumatoid arthritis and psoriasis by modulating signaling pathways that control cytokine production and cell proliferation. Its structure allows for high binding affinity to the target kinase, improving therapeutic efficacy while reducing off-target effects. Currently under investigation for potential use in oncology due to its ability to interfere with tumor cell growth and survival pathways.